Latest Odronextamab Data in Relapsed/Refractory Follicular
Updated results presented at ASH demonstrated an 80% objective response rate and a 73% complete response (CR), with a 23-month ...
Read moreUpdated results presented at ASH demonstrated an 80% objective response rate and a 73% complete response (CR), with a 23-month ...
Read morePhase 2 primary analysis results presented in ASH oral session demonstrated a 52% objective response rate (ORR), with 31% achieving ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.